Metabolic Changes During Gonadotropin-releasing Hormone Agonist Therapy for Prostate Cancer: Differences From the Classic Metabolic Syndrome

BACKGROUND: In men with prostate cancer, gonadotropin-releasing hormone (GnRH) agonists increase fat mass, decrease insulin sensitivity, and increase triglycerides, features that are shared with metabolic syndrome. To the authors’ knowledge, however, less is known regarding the effects of GnRH agoni...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Smith, Matthew R., Lee, Hang, McGovern, Francis, Fallon, Mary Anne, Goode, Melissa, Zietman, Anthony L., Finkelstein, Joel S.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2008
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2562782/
https://ncbi.nlm.nih.gov/pubmed/18348297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23440
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים